Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ela Erdem is active.

Publication


Featured researches published by Ela Erdem.


Pediatrics International | 2010

Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.

Sema Vural; Ela Erdem; Seda Geylani Gulec; Yildiz Yildirmak; Rejin Kebudi

Background:  In view of the recent trend toward monotherapy in the treatment of febrile neutropenia, we evaluated the clinical efficacy and safety of imipenem–cilastatin versus piperacillin–tazobactam as an empiric therapy for febrile neutropenia in children with malignant diseases.


Pediatric Blood & Cancer | 2012

Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.

Serap Karaman; Sema Vural; Yildiz Yildirmak; Merve Emecen; Ela Erdem; Rejin Kebudi

Monotherapy has tended to replace the combination therapy in emprical treatment of febrile neutropenia. There is no reported trial which compares the efficacy of cefoperazone‐sulbactam (CS) and piperacillin‐tazobactam (PIP/TAZO) monotherapies in the treatment of febrile neutropenia. In this prospective randomized study, we aimed to compare the safety and efficacy of CS versus PIP/TAZO as empirical monotherapies in febrile neutropenic children with cancer.


Annals of Tropical Paediatrics | 2003

Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.

Ayse Palanduz; Derya Gültekin; Ela Erdem; Nimet Kayaalp

Abstract Patient compliance should be ensured in an effective tuberculosis control programme. We measured patient compliance by detecting antituberculous drugs in the urine of 237 outpatients receiving one to three antituberculous drugs. Positive controls were 20 hospitalised patients, supervised to receive isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA), and negative controls were not on any drugs. Among the 237 study patients, only 67% were found to be taking the appropriate treatment and 8% had taken none. We conclude that a remarkable number of patients (33%) were non-compliant with treatment. The detection of antituberculous drugs in the urine is a quick, simple and inexpensive means of measuring adherence to treatment. Unless directly observed therapy (DOT) is adopted, we recommend routine urine testing for antituberculous drugs to identify defaulting patients.


Yonsei Medical Journal | 2012

Description of pediatric tuberculosis evaluated in a referral center in istanbul Turkey.

Seda Geylani Gulec; Leyla Telhan; Tanyel Koçkaya; Ela Erdem; Banu Bayraktar; Ayse Palanduz

Purpose Diagnosis of tuberculosis (TB) in children is more challenging than in adults. This study aimed to describe demographical, clinical and laboratory findings of children diagnosed with tuberculosis in Turkey, including the issues of contact tracing, culture positivity and forms of the disease. Materials and Methods Clinical and laboratory data of 51 children with a mean age of 8.0±4.6 years who were diagnosed with TB were retrospectively reviewed. Main diagnostic tools included tuberculin skin test, chest X-ray, sputum/gastric aspirate culture with sensitivity testing, and direct microscopy for acid-fast bacilli on available samples. Clinical characteristics and outcomes of the patients were examined. Results Thirty-six (70.6%) children were diagnosed with intra-thoracic and 15 (29.4%) with extra-thoracic tuberculosis. Twenty-eight of the patients had a positive Bacillus Calmette-Guérin vaccine scar (28/51, 54.9%) and 23/51 (45.1%) had a positive tuberculin skin test. An adult TB contact was identified in 27 (52.9%) of the cases. On direct microscopy, acid-fast bacilli were found in nine (17.6%) patients and positive culture for Mycobacterium tuberculosis was found in 19 (37.3%). Drug resistance to isoniazid was detected in four (7.8%). One patient with nephrotic syndrome and miliary tuberculosis died during follow-up. All other patients responded well to the treatment. Conclusion Focusing on active contact tracing among all household contacts of tuberculous cases may be helpful in early identification and controlling childhood disease, even in regions with low disease prevalence. Adopting a suspicious and proactive approach in this particular age group is warranted.


Indian Journal of Hematology and Blood Transfusion | 2011

Rare presentation of pediatric acute lymphoblastic leukemia: nephromegaly at time of diagnosis.

Ela Erdem; Petek Kayiran; Gül Özçelik; Alper Ozel; Z. Yildiz Yildirmak

Renal involvement is a fairly frequent development in children with acute lymphoblastic leukemia, but palpable renal enlargement at time of diagnosis is very unusual. We report the case of a young girl who presented with enlarged kidneys and was diagnosed with this form of leukemia. This case is of interest because of the rarity of this presentation. The importance of renal biopsy in identifying the etiology of this patient’s nephromegaly is emphasized.


Pediatric Emergency Care | 2011

Acute Liver Failure, Autoimmune Hepatitis, and Leptospirosis: A Case Report

Nafiye Urganci; Derya Kalyoncu; Nihal Cayonu; Ela Erdem; Yildiz Yildirmak; Banu Yilmaz

The etiology of acute liver failure varies widely in children, but the most common causes are viral hepatitis, drugs, and toxins. We report herein a case of autoimmune hepatitis and acute liver failure caused by leptospirosis, which is involved rarely in etiology.


Turkish journal of haematology : official journal of Turkish Society of Haematology | 2012

Immunosuppressive treatment in children with acquired aplastic anemia.

Yildiz Yildirmak; Ela Erdem; Leyla Telhan; Laliz Kepekçi

Objective: Immunosuppressive treatment (IST) is an alternative for children with acquired aplastic anemia (AA) that do not have HLA-matched donors. The objective of this study was to evaluate the outcome of IST in children with acquired AA. Material and Methods: The study included 18 pediatric acquired AA patients that were retrospectively evaluated. The patients either did not have an HLA-matched related donor or were unable to undergo transplantation within 6 months despite having an HLA-matched donor. Results: In all, 6 of the patients were characterized as very severe AA, 6 as severe AA, and 6 as moderate AA. Mean duration of follow-up was 44.5 months. In total, 9 patients that could not be treated with equine anti-thymocyte globulin (hATG) following diagnosis received high-dose methylprednisolone treatment. Among the 6 very severe AA patients, 2 achieved complete remission (22%); the other 16 patients received hATG+cyclosporine and short-term methylprednisolone. In total, 4 of the patients died during the first month of treatment. Of the remaining 12 patients, 3 responded to the treatment (25%). Of the 9 patients that did not respond after 3 months of treatment, 7 received a second course of immunosuppressive treatment with rabbit ATG (rATG)+cyclosporine and short-term methylprednisolone; 2 of the 7 patients responded (22%), but 5 did not respond to any treatment. Median survival among the patients was as 64 ± 8 months Conclusion: Combination IST with ATG+cyclosporine and low-dose methylprednisolone was an effective treatment in the pediatric acquired AA patients with non-identical HLA donors. In the patients that couldn’t be treated with ATG high-dose methylprednisolone treatment was safe and effective.


Turkish journal of haematology : official journal of Turkish Society of Haematology | 2011

Brucellosis presenting with pancytopenia due to hemophagocytic syndrome.

Ela Erdem; Yildiz Yildirmak; Nursen Gunaydin

Reactive hemophagocytic syndrome is clinically characterized by fever, hepatosplenomegaly, pancytopenia, and coagulopathy, and is histologically characterized by excessive proliferation and activation of histiocytes or macrophages. It can occur with systemic infections, immunodeficiency, or underlying malignancy. Brucellosis is one of the rare causes of hemophagocytosis. Herein we report an 11-year-old male with pancytopenia due to hemophagocytosis during the course of brucellosis that responded favorably to therapy. Although rare, hemophagocytosis should be considered as a possible cause of pancytopenia in patients with brucellosis, especially in regions where brucellosis is frequently encountered.


Iranian Journal of Pediatrics | 2010

Hepatitis a with pleural effusion, ascites and acalculous cholecystitis.

Ela Erdem; Yasemin Ceylan; Nursu Kara; Gul Ozcelik; Seda Geylani Gulec


Iranian Journal of Pediatrics | 2012

A case report of malignant infantile osteopetrosis.

Merve Usta; Seda Geylani Gulec; Serap Karaman; Ela Erdem; Hicran Emral; Nafiye Urganci

Collaboration


Dive into the Ela Erdem's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge